Jack A. Khattar - 15 Feb 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
15 Feb 2023
Transactions value $
$0
Form type
4
Filing time
16 Feb 2023, 16:00:25 UTC
Previous filing
06 Feb 2023
Next filing
21 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Other +8.75K +1.09% 813K 15 Feb 2023 Direct F1
transaction SUPN Common Stock Other -8.75K -0.84% 1.04M 15 Feb 2023 By the KBT Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to reflect the fact that 8,750 shares were transferred from the KBT Trust to the Reporting Person on February 15, 2023 without consideration and are now owned directly.